RACHEL ROTH: Open Payments
NPI 1609547926 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 18 payments from 12 companies in 2025. Trend: 2023 $568 · 2024 $660 · 2025 $501
Food & beverage: $396Consulting: $105
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $105 |
| ABBVIE INC. | 4 | $85 |
| Intra-Sana Laboratories | 1 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| GENZYME CORPORATION | 1 | $41 |
| Lilly USA, LLC | 2 | $38 |
| TOLMAR, INC. | 2 | $34 |
| Novo Nordisk Inc | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| PFIZER INC. | 1 | $18 |
Products named: Leqembi, VRAYLAR, RELTONE 200 MG, DUPIXENT, JARDIANCE, JATENZO, Rybelsus, SHINGRIX.
Industry payments across CA — which companies pay providers there.
